Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Non Operating Income (2020 - 2025)

Rapid Micro Biosystems' Non Operating Income history spans 6 years, with the latest figure at -$125000.0 for Q3 2025.

  • For Q3 2025, Non Operating Income fell 220.51% year-over-year to -$125000.0; the TTM value through Sep 2025 reached $3.4 million, up 202.93%, while the annual FY2024 figure was $3.1 million, 3777.11% up from the prior year.
  • Non Operating Income for Q3 2025 was -$125000.0 at Rapid Micro Biosystems, down from -$50000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $25.3 million in Q4 2021 and bottomed at -$26.2 million in Q3 2021.
  • The 5-year median for Non Operating Income is -$23000.0 (2024), against an average of $17578.9.
  • The largest YoY upside for Non Operating Income was 1266900.0% in 2021 against a maximum downside of 761.86% in 2021.
  • A 5-year view of Non Operating Income shows it stood at $25.3 million in 2021, then crashed by 96.76% to $820000.0 in 2022, then plummeted by 488.54% to -$3.2 million in 2023, then skyrocketed by 198.65% to $3.1 million in 2024, then tumbled by 103.98% to -$125000.0 in 2025.
  • Per Business Quant, the three most recent readings for RPID's Non Operating Income are -$125000.0 (Q3 2025), -$50000.0 (Q2 2025), and $405000.0 (Q1 2025).